Skip to the main content.
Other Therapy Areas

Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.

Learn More →

Blog | Veristat Insightful Perspectives

Gain the latest insights and trends in clinical trials, patient recruitment, data analysis, adaptive design, regulatory submissions and approvals.

Posts about

Regulatory Submissions (13)

Regulatory Guidance Monthly Review - January 2020

January 2020 

Each month, Veristat's regulatory team tracks and shares a selection of new...

Regulatory Guidance Monthly Review - December 2019

December 2019 

Each month, Veristat's regulatory team tracks and shares a selection of new...

Regulatory Guidance Monthly Review - November 2019

November 2019 Updates from FDA 

Each month, Veristat's regulatory team tracks and shares a...

Understanding When to Submit an IND Application to the FDA

An Interview with Kevin Hennegan, Director, North American Regulatory Affairs at Veristat

Regulatory Guidance Monthly Review - October 2019

October 2019 Updates from FDA 

Each month, Veristat's regulatory team tracks and shares a...

Regulatory Guidance Monthly Review - September 2019

September 2019 Updates from FDA 

Each month, Veristat's regulatory team tracks and shares a...

Regulatory Guidance Monthly Review - August 2019

August 2019 Updates from FDA 

Each month, Veristat's regulatory team tracks and shares a selection...

Regulatory Guidance Monthly Review - July 2019

July 2019 Updates from FDA 

Each month, Veristat's regulatory team tracks and shares a selection...

Regulatory Guidance Monthly Review - June 2019

June 2019 Updates from FDA 

Each month, Veristat's regulatory team tracks and shares a selection...

Regulatory Guidance Review - May 2019

May 2019 Updates from FDA 

Each month, Veristat's regulatory team tracks and shares a selection of...